{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:58:12Z","timestamp":1747159092873,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.dld.2024.06.014","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:56:53Z","timestamp":1719921413000},"page":"1646-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on: Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6627-4135","authenticated-orcid":false,"given":"Izza","family":"Shakeel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6839-3289","authenticated-orcid":false,"given":"Maryam","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1164-4120","authenticated-orcid":false,"given":"Isma","family":"Farid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2024.06.014_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dld.2023.04.017","article-title":"Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study","volume":"56","author":"Fumery","year":"2024","journal-title":"Digest Liver Disease"},{"key":"10.1016\/j.dld.2024.06.014_bib0002","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ibd\/izad138","article-title":"Real-world effectiveness of vedolizumab vs anti-TNF in biologic-na\u00efve crohn's disease patients: A 2-year propensity-score-adjusted analysis from the VEDOIBD-study","volume":"30","author":"Bokemeyer","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2024.06.014_bib0003","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.06.014_bib0004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2468-1253(22)00385-5","article-title":"Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Louis","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.06.014_bib0005","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cgh.2020.02.009","article-title":"Predicting, preventing, and managing treatment-related complications in patients with inflammatory bowel diseases","volume":"18","author":"Beaugerie","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.06.014_bib0006","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000502515","article-title":"Distinct association of serum vitamin D concentration with disease activity and trough levels of infliximab and adalimumab during inflammatory bowel disease treatment","volume":"101","author":"Mechie","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2024.06.014_bib0007","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1097\/MPG.0000000000003064","article-title":"The impact of vitamin D on response to anti-tumor necrosis factor-\u03b1 therapy in children with inflammatory bowel disease","volume":"72","author":"Hizarcioglu-Gulsen","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2024.06.014_bib0008","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MPG.0000000000003730","article-title":"Clinical course of very early-onset inflammatory bowel disease","volume":"76","author":"Cucinotta","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2024.06.014_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000351","article-title":"Impact of comorbidities on anti-TNF\u03b1 response and relapse in patients with inflammatory bowel disease: the VERNE study","volume":"7","author":"Marin-Jimenez","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.dld.2024.06.014_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050404","article-title":"Genetic studies of inflammatory bowel disease-focusing on Asian patients","volume":"8","author":"Park","year":"2019","journal-title":"Cells"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824008247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824008247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:35:05Z","timestamp":1725377705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824008247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1590865824008247"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.06.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on: Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.04.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}